Back to top

medical-devices: Archive

Zacks Equity Research

Philips' (PHG) Reports Positive AI-Powered Cardiac Study Data

Philips' (PHG) AI-powered cardiac monitoring solutions demonstrate significantly lower re-admissions and a higher rate of survival in the retrospective study evaluating it in stroke patients.

BSXPositive Net Change ECLPositive Net Change PHGNegative Net Change ALGNNegative Net Change

Zacks Equity Research

Masimo's (MASI) New Offering to Serve Personalized Audio Market

Masimo's (MASI) new product offering is expected to enable it to expand its footprint in the personalized hearables market by offering personalized listening experiences.

ECLPositive Net Change DVAPositive Net Change MASIPositive Net Change VEEVNegative Net Change

Zacks Equity Research

Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?

Investors are optimistic about Boston Scientific's (BSX) impressive market share gain in the MedSurg segment and continued geographical expansion.

BSXPositive Net Change ECLPositive Net Change DVAPositive Net Change VEEVNegative Net Change

Zacks Equity Research

Here's Why You Should Hold Surmodics (SRDX) Stock for Now

Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.

DVAPositive Net Change ALGNNegative Net Change SRDXPositive Net Change MEDPPositive Net Change

Zacks Equity Research

Here's Why Investors Should Buy ResMed (RMD) Stock Now

Investors are optimistic about ResMed's (RMD) potential in digital health and expansion in the international market.

RMDPositive Net Change MEDPPositive Net Change HIMSPositive Net Change HITINegative Net Change

Zacks Equity Research

Boston Scientific (BSX) mCRM System Study Outcome Favorable

Boston Scientific (BSX) mCRM System is designed to communicate wirelessly and coordinate painless intracardiac anti-tachycardia pacing (ATP) therapy.

BSXPositive Net Change RMDPositive Net Change MEDPPositive Net Change EHCPositive Net Change

Zacks Equity Research

Medtronic (MDT) Reports Favorable SPHERE Per-AF Trial Outcome

Medtronic's (MDT) Affera Mapping and Ablation System with Sphere-9 Catheter achieves endpoints for safety and efficacy for the treatment of AFib.

MDTNegative Net Change MEDPPositive Net Change HIMSPositive Net Change HITINegative Net Change

Zacks Equity Research

Veeva's (VEEV) Vault Basics to Boost Efficiency for Biotechs

Veeva (VEEV) announces the availability of Vault Basics for biotechs, which aims to deliver complete and pre-validated solutions for expanding businesses.

BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change VEEVNegative Net Change

Zacks Equity Research

AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft

AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.

BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change AXGNPositive Net Change

Zacks Equity Research

BD's (BDX) FDA-Approved Test to Offer Wider Testing Access

BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.

ECLPositive Net Change BDXPositive Net Change DVAPositive Net Change VEEVNegative Net Change

Zacks Equity Research

Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?

Investors are optimistic about Haemonetics (HAE) led by its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns.

RMDPositive Net Change HAENegative Net Change MEDPPositive Net Change EHCPositive Net Change

Zacks Equity Research

Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?

Tandem Diabetes (TNDM) outperforms the industry, owing to its impressive series of product launches and an impressive quarterly performance.

CAHNegative Net Change TNDMNegative Net Change MEDPPositive Net Change HITINegative Net Change

Zacks Equity Research

Reasons to Retain DexCom (DXCM) Stock in Your Portfolio Now

DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.

DVAPositive Net Change ALGNNegative Net Change ALCNegative Net Change DXCMNegative Net Change

Zacks Equity Research

Butterfly Network (BFLY) Unveils iQ+ Bladder Ultrasound Scanner

Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.

DVAPositive Net Change ALGNNegative Net Change MEDPPositive Net Change BFLYPositive Net Change

Zacks Equity Research

Three Reasons to Retain AMN Healthcare (AMN) Stock for Now

Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.

ECLPositive Net Change DVAPositive Net Change AMNPositive Net Change VEEVNegative Net Change

Zacks Equity Research

HealthEquity (HQY) Closes Conduent's BenefitWallet Acquisition

HealthEquity (HQY) completes the acquisition of Conduent's BenefitWallet HSA portfolio. This is likely to further strengthen the HSA business of HealthEquity.

BSXPositive Net Change ECLPositive Net Change ALGNNegative Net Change HQYPositive Net Change

Zacks Equity Research

Labcorp (LH) to Assess Preeclampsia Risk With New Test

Labcorp's (LH) new first-trimester test is the latest addition to its dedication to improving women's health.

LHNegative Net Change RMDPositive Net Change MEDPPositive Net Change EHCPositive Net Change

Zacks Equity Research

Profound Medical (PROF) Adds AI to Prostate Cancer Treatment

Profound Medical's (PROF) Contouring Assistant integrates AI into prostate cancer procedures, thereby streamlining the treatment planning process and enhancing both efficiency and precision.

DVAPositive Net Change ALGNNegative Net Change MEDPPositive Net Change PROFNegative Net Change

Zacks Equity Research

Thermo Fisher (TMO) Unveils New Extended Blood Genotyping Array

Thermo Fisher's (TMO) new Applied Biosystems Axiom BloodGenomiX Array and Software provide a high-throughput solution for more precise blood matching research.

TMONegative Net Change MEDPPositive Net Change HIMSPositive Net Change HITINegative Net Change

Zacks Equity Research

Here's Why Investors Should Retain QIAGEN (QGEN) Stock Now

QIAGEN's (QGEN) solid potential in the NGS platform buoys optimism for investors.

QGENNegative Net Change MEDPPositive Net Change HIMSPositive Net Change HITINegative Net Change